Trial intelligence / Profile preview

Remimazolam besylate + sufentanil vs propofol + sufentanil for postoperative delirium after cardiac surgery

ChiCTR2000038976Phase 4Recruiting

Sponsor
Liaocheng Cardiac Hospital
Start
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in postoperative delirium (POD) and Postcardiac surgery state (2 arms), sponsored by Liaocheng Cardiac Hospital. Primary endpoint: Incidence of delirium. Started Jul 2020; status: recruiting.

02

Drugs

remimazolam
03

Conditions

postoperative delirium (POD)Postcardiac surgery state

Beyond the preview

Go deeper on ChiCTR2000038976.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000038976.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call